Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 70


High-Dose, Single-Fraction Irradiation Rapidly Reduces Tumor Vasculature and Perfusion in a Xenograft Model of Neuroblastoma.

Jani A, Shaikh F, Barton S, Willis C, Banerjee D, Mitchell J, Hernandez SL, Hei T, Kadenhe-Chiweshe A, Yamashiro DJ, Connolly EP.

Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1173-80. doi: 10.1016/j.ijrobp.2015.12.367. Epub 2015 Dec 29.


Inhibition of Notch promotes liver metastasis.

Banerjee D, Kadenhe-Chiweshe A, Yamashiro DJ.

Aging (Albany NY). 2015 Sep;7(9):603-4. No abstract available.


Notch suppresses angiogenesis and progression of hepatic metastases.

Banerjee D, Hernandez SL, Garcia A, Kangsamaksin T, Sbiroli E, Andrews J, Forrester LA, Wei N, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ.

Cancer Res. 2015 Apr 15;75(8):1592-602. doi: 10.1158/0008-5472.CAN-14-1493. Epub 2015 Mar 5.


Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis.

Hernandez SL, Banerjee D, Garcia A, Kangsamaksin T, Cheng WY, Anastassiou D, Funahashi Y, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ.

Vasc Cell. 2013 Sep 25;5(1):17. doi: 10.1186/2045-824X-5-17.


A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties.

Ma TC, Langley B, Ko B, Wei N, Gazaryan IG, Zareen N, Yamashiro DJ, Willis DE, Ratan RR.

Neurobiol Dis. 2013 Jan;49:13-21. doi: 10.1016/j.nbd.2012.08.016. Epub 2012 Aug 27.


A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report.

Glade Bender J, Blaney SM, Borinstein S, Reid JM, Baruchel S, Ahern C, Ingle AM, Yamashiro DJ, Chen A, Weigel B, Adamson PC, Park JR.

Clin Cancer Res. 2012 Sep 15;18(18):5081-9. Epub 2012 Jul 12.


A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma.

Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D.

PLoS One. 2012;7(4):e34705. doi: 10.1371/journal.pone.0034705. Epub 2012 Apr 6.


Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy.

Sirsi SR, Flexman ML, Vlachos F, Huang J, Hernandez SL, Kim HK, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Hielscher AH, Kandel JJ, Yamashiro DJ, Borden MA.

Ultrasound Med Biol. 2012 Jun;38(6):1019-29. doi: 10.1016/j.ultrasmedbio.2012.01.014. Epub 2012 Mar 16.


Monitoring early tumor response to drug therapy with diffuse optical tomography.

Flexman ML, Vlachos F, Kim HK, Sirsi SR, Huang J, Hernandez SL, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Borden MA, Yamashiro DJ, Kandel JJ, Hielscher AH.

J Biomed Opt. 2012 Jan;17(1):016014. doi: 10.1117/1.JBO.17.1.016014.


Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo.

Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ.

BMC Cancer. 2011 Dec 30;11:529. doi: 10.1186/1471-2407-11-529.


Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

Glade Bender J, Yamashiro DJ, Fox E.

Oncologist. 2011;16(11):1614-25. doi: 10.1634/theoncologist.2011-0148. Epub 2011 Oct 31. Review.


Inhibition of cyclo-oxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor.

Fisher JC, Gander JW, Haley MJ, Hernandez SL, Huang J, Chang YJ, Johung TB, Guarnieri P, O'Toole K, Yamashiro DJ, Kandel JJ.

Vasc Cell. 2011 Oct 6;3:22. doi: 10.1186/2045-824X-3-22.


Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors.

Sirsi SR, Hernandez SL, Zielinski L, Blomback H, Koubaa A, Synder M, Homma S, Kandel JJ, Yamashiro DJ, Borden MA.

J Control Release. 2012 Jan 30;157(2):224-34. doi: 10.1016/j.jconrel.2011.09.071. Epub 2011 Sep 17.


A common symptom of an uncommon disease.

Sia VM, Sia DC, Yamashiro DJ, Middlesworth W, Syed M, Paudel G, Kirk R, Kigongo-Mwesezi S, Rivlin K, Leggiadro RJ.

J Pediatr Hematol Oncol. 2011 Jul;33(5):390-1. doi: 10.1097/MPH.0b013e3181ff0f14.


PDE-constrained multispectral imaging of tissue chromophores with the equation of radiative transfer.

Kim HK, Flexman M, Yamashiro DJ, Kandel JJ, Hielscher AH.

Biomed Opt Express. 2010 Sep 8;1(3):812-824.


Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review.

Boo YJ, Fisher JC, Haley MJ, Cowles RA, Kandel JJ, Yamashiro DJ.

J Pediatr Surg. 2009 Oct;44(10):2031-6. doi: 10.1016/j.jpedsurg.2009.06.023. Review.


The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review.

Rothenberg AB, Berdon WE, D'Angio GJ, Yamashiro DJ, Cowles RA.

Pediatr Radiol. 2009 Jul;39(7):723-6. doi: 10.1007/s00247-009-1282-x. Epub 2009 May 9.


Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma.

Zaghloul N, Hernandez SL, Bae JO, Huang J, Fisher JC, Lee A, Kadenhe-Chiweshe A, Kandel JJ, Yamashiro DJ.

Int J Oncol. 2009 Feb;34(2):401-7.


Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab.

Levy CF, Oo KZ, Fireman F, Pierre L, Bania MA, Sadanandan S, Yamashiro DJ, Glade Bender JL.

Pediatr Blood Cancer. 2009 May;52(5):669-71. doi: 10.1002/pbc.21866.


Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade.

Huang J, Bae JO, Tsai JP, Kadenhe-Chiweshe A, Papa J, Lee A, Zeng S, Kornfeld ZN, Ullner P, Zaghloul N, Ioffe E, Nandor S, Burova E, Holash J, Thurston G, Rudge J, Yancopoulos GD, Yamashiro DJ, Kandel JJ.

Int J Oncol. 2009 Jan;34(1):79-87.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk